Solventum Corp reported $14.1B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Align Technology USD 6.31B 80.48M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Cencora USD 78.36B 1.77B Dec/2025
Dexcom USD 6.63B 293.4M Mar/2026
Insulet USD 2.99B 203.2M Mar/2026
Solventum Corp USD 14.1B 197M Mar/2026
West Pharmaceutical Services USD 4.11B 160.2M Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026